Biocryst Pharmaceuticals (BCRX) Capital Leases (2015 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Capital Leases came in at $1.2 million in Q1 2026, down 49.31% YoY from $2.3 million in Q1 2025, and down 18.6% on a QoQ basis from $1.4 million in Q4 2025.
Biocryst Pharmaceuticals (BCRX) Capital Leases (2015 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 12 years of Capital Leases data on file, last reported at $1.2 million in Q1 2026.
- Quarterly Capital Leases fell 49.31% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 49.31% YoY) and the FY2025 annual result came in at $1.4 million, down 32.16% from the prior year.
- Capital Leases retreated to $1.2 million in Q1 2026, from $1.4 million in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $2.8 million in Q4 2023 to a low of $1.2 million in Q1 2026.
- A 5-year average of $2.0 million and a median of $2.1 million in 2024 frame the typical range for Capital Leases.
- Annual changes were most pronounced in 2023 — Capital Leases jumped 60.1% — and 2026, when it slumped 49.31%.
- Tracing BCRX's Capital Leases over 5 years: stood at $1.8 million in 2022, then jumped by 60.1% to $2.8 million in 2023, then retreated by 25.34% to $2.1 million in 2024, then slumped by 32.16% to $1.4 million in 2025, then dropped by 18.6% to $1.2 million in 2026.
- The last three Capital Leases figures came in at $1.2 million (Q1 2026), $1.4 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Biocryst Pharmaceuticals | 2.43 Bn | 2.08 Bn | 214.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 849,000.00 |
| Mar 31, 2026 | 1.17 Mn |
| Dec 31, 2025 | 1.44 Mn |
| Sep 30, 2025 | 1.74 Mn |
| Jun 30, 2025 | 2.04 Mn |
| Mar 31, 2025 | 2.31 Mn |
| Dec 31, 2024 | 2.12 Mn |
| Sep 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | 2.12 Mn |
| Mar 31, 2024 | 2.51 Mn |
| Dec 31, 2023 | 2.85 Mn |
| Dec 31, 2022 | 1.78 Mn |
| Sep 30, 2021 | 5.04 Mn |
| Jun 30, 2021 | 4.10 Mn |
| Mar 31, 2021 | 3.88 Mn |
| Dec 31, 2020 | 3.87 Mn |
| Sep 30, 2020 | 3.92 Mn |
| Mar 31, 2020 | 3.73 Mn |
| Dec 31, 2019 | 3.41 Mn |
| Dec 31, 2018 | 2.70 Mn |